Vaccines save lives by protecting people against infectious diseases—polio, influenza, and malaria to name a few. Kaiser Permanente Washington Health Research Institute (KPWHRI) is working to protect communities through research to continually improve the safety and effectiveness of vaccines and other treatments for infectious diseases as well as cancer. We also test new vaccines that may stop the threat of emerging diseases such as the novel coronavirus (SARS-CoV-2), which causes COVID-19.
Our research projects on vaccines and infectious diseases include:
Successes over 3 decades of KPWHRI research on vaccines and preventing and treating infectious disease include:
Dublin S, Walker RL, Floyd JS, Shortreed SM, Fuller S, Albertson-Junkans LH, Harrington LB, Greenwood-Hickman MA, Green BB, Psaty BM. Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study. medRxiv. 2020:2020.07.06.20120386. doi: 10.1101/2020.07.06.20120386. PubMed
Williams EC, McGinnis KA, Rubinsky AD, Matson TE, Bobb JF, Lapham GT, Edelman EJ, Satre DD, Catz SL, Richards JE, Bryant KJ, Marshall BDL, Kraemer KL, Crystal S, Gordon AJ, Skanderson M, Fiellin DA, Justice AC, Bradley KA. Alcohol use and antiretroviral adherence among patients living with HIV: is change in alcohol use associated with change in adherence? AIDS Behav. 2020 Jul 2. doi: 10.1007/s10461-020-02950-x. [Epub ahead of print]. PubMed
Hesse EM, Navarro RA, Daley MF, Getahun D, Henninger ML, Jackson LA, Nordin J, Olson SC, Zerbo O, Zheng C, Duffy J. Risk for subdeltoid bursitis after influenza vaccination: a population-based cohort study. Ann Intern Med. 2020 Jun 23. doi: 10.7326/M19-3176. [Epub ahead of print]. PubMed
Jackson ML, Scott E, Kuypers J, Nalla AK, Roychoudury P, Chu HY. Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16. LID - jiaa331 [pii] LID - 10.1093/infdis/jiaa331 [doi] J Infect Dis. 2020 Jun 19:jiaa331. doi: 10.1093/infdis/jiaa331 [Epub ahead of print] PubMed
Parodi S, Choucair B, Young S, Bellow J, Grossman D, Liu VX. Kaiser Permanente’s system capabilities to suppress Covid-19. N Eng J Med Catal. June 9, 2020. DOI: 10.1056/CAT.20.0187.
![]() Lisa A. Jackson, MD, MPHSenior Investigator |
![]() Jennifer C. Nelson, PhDDirector of Biostatistics; Senior Investigator |
![]() Michael L. Jackson, PhD, MPHSenior Investigator |
![]() Andrea J. Cook, PhDSenior Investigator |
![]() Sascha Dublin, MD, PhDSenior Investigator |
![]() Onchee Yu, MSBiostatistician III |
![]() Robert D. Wellman, MSBiostatistician III |
Doug Opel, MD, MPH
University of Washington (UW) Department of Bioethics and Humanities; UW Department of Pediatrics; UW Medical Center
John Dunn, MD, MPH
Kaiser Foundation Health Plan of Washington
Elizabeth Lin, MD, MPH
Kaiser Foundation Health Plan of Washington Family Practice;
Kaiser Permanente Washington Health Research Institute